Press releases
- Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
- Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
- Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition
- Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
- Bruker Corporation to Present at Upcoming Investor Conferences
- Bruker Announces Quarterly Dividend
- Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
- Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 57.79 |
---|---|
High | 57.79 |
Low | 57.79 |
Bid | 55.63 |
Offer | 56.52 |
Previous close | 57.79 |
Average volume | -- |
---|---|
Shares outstanding | 137.67m |
Free float | 89.95m |
P/E (TTM) | 28.52 |
Market cap | 11.42bn USD |
EPS (TTM) | 2.91 USD |
Annual div (ADY) | 0.1769 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of Feb 16 2021.
More ▼